PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved properties Grant US-11932675-B2 United States of America 19 Mar 2024
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both… Grant US-11883398-B2 United States of America 30 Jan 2024
Compositions for cancer therapy and methods Grant US-11813279-B2 United States of America 14 Nov 2023
CD37-binding molecules and immunoconjugates thereof Grant US-11466095-B2 United States of America 11 Oct 2022
Lymphocyte and monocyte populations in cancer patients and autologous stem cell… Grant US-11439684-B2 United States of America 13 Sep 2022
METHODS FOR PREDICTING THE SURVIVAL TIME AND TREATMENT RESPONSIVENESS OF A PATIENT… Application US-20220259665-A1 United States of America 18 Aug 2022
Methods of using interleukin-10 for treating diseases and disorders Grant US-11413332-B2 United States of America 16 Aug 2022
Anti-CD37 immunoconjugate and anti-CD20 antibody combinations Grant US-11395796-B2 United States of America 26 Jul 2022
Novel methods for the in vitro processing of cancer cells from one individual to… Application US-20220204639-A1 United States of America 30 Jun 2022
Pharmaceutical combinations comprising an anti-LY75 antibody Grant US-11365258-B2 United States of America 21 Jun 2022
DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES Application US-20220162329-A1 United States of America 26 May 2022
ANTIBODIES BINDING TO HUMAN CD3 AT ACIDIC pH Application US-20220135680-A1 United States of America 05 May 2022
DIPEPTIDYLPEPTIDASE 4 INHIBITION ENHANCES LYMPHOCYTE TRAFFICKING, IMPROVING BOTH… Application US-20220117960-A1 United States of America 21 Apr 2022
ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF Application US-20220089754-A1 United States of America 24 Mar 2022
Methods for improving anti-CD37 immunoconjugate therapy Grant US-11278629-B2 United States of America 22 Mar 2022
IMMUNO ONCOLOGY COMBINATION THERAPY WITH IL-2 CONJUGATES AND ANTI-EGFR ANTIBODIES Application US-20220016252-A1 United States of America 20 Jan 2022
ANTI-SIGLEC-5 ANTIBODIES AND METHODS OF USE THEREOF Application US-20210395361-A1 United States of America 23 Dec 2021
METHODS OF USING SPLICING MODULATORS Application US-20210346371-A1 United States of America 11 Nov 2021
Antibodies and assays for detection of CD37 Grant US-11104740-B2 United States of America 31 Aug 2021
COMPOSITIONS FOR CANCER THERAPY AND METHODS Application US-20210196744-A1 United States of America 01 Jul 2021
Novel Immune Checkpoint Inhibitors Application US-20210171631-A1 United States of America 10 Jun 2021
ANTIBODIES TO PROGRAMMED DEATH LIGAND (PD-L1) AND APPLICATION THEREOF Application US-20210171638-A1 United States of America 10 Jun 2021
RAMUCIRUMAB FOR THE TREATMENT OF CANCERS IN PEDIATRIC PATIENTS Application US-20210163605-A1 United States of America 03 Jun 2021
COMPOSITIONS AND METHODS FOR CELL TARGETING THERAPIES Application US-20200368278-A1 United States of America 26 Nov 2020
Antibodies selective for cells presenting EGFR at high density Grant US-10570211-B2 United States of America 25 Feb 2020
Agents for treatment of claudin expressing cancer diseases Grant US-10093736-B2 United States of America 09 Oct 2018
Conjugated antibodies against LY75 for the treatment of cancer Grant US-10081682-B2 United States of America 25 Sep 2018
INHIBITION OF CXCR4 SIGNALING IN CANCER IMMUNOTHERAPY Application US-20180228894-A1 United States of America 16 Aug 2018
PREVENTION OF METASTASIS AND RECURRENCE AFTER PRIMARY CANCER TREATMENT Application US-20180194836-A1 United States of America 12 Jul 2018
Pharmaceutical composition for treatment of radiation- or drug-resistant cancer… Grant US-9963701-B2 United States of America 08 May 2018
Pharmaceutical compositions containing sc(Fv)2 Grant US-9777066-B2 United States of America 03 Oct 2017
Use of Th9 cells and IL-9 for the treatment of melanoma Application US-9629910-B2 United States of America 25 Apr 2017
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF RADIATION- OR DRUG-RESISTANT CANCER… Application US-20160298119-A1 United States of America 13 Oct 2016
Methods of Using Interleukin-10 for Treating Diseases and Disorders Application US-20160243196-A1 United States of America 25 Aug 2016
Pharmaceutical compositions containing sc(Fv)2 Grant US-9241994-B2 United States of America 26 Jan 2016
INHIBITION OF CXCR4 SIGNALING IN CANCER IMMUNOTHERAPY Application US-20150352208-A1 United States of America 10 Dec 2015
LY75 AS CANCER THERAPEUTIC AND DIAGNOSTIC TARGET Application US-20150297743-A1 United States of America 22 Oct 2015
Combination of a phosphoinositide 3-kinase inhibitor and an inhibitor of the IL-8/CXCR… Application US-20150224190-A1 United States of America 13 Aug 2015
INHIBITION OF CXCR4 SIGNALING IN CANCER IMMUNOTHERAPY Application US-20150216843-A1 United States of America 06 Aug 2015
CANCER STEM CELL TARGETED CANCER VACCINES Application US-20150139939-A1 United States of America 21 May 2015
Oncotherapeutic application of inhibitors of high-affinity glucose transporters Grant US-8999326-B2 United States of America 07 Apr 2015
Stabilizer for protein preparation comprising meglumine and use thereof Grant US-8945543-B2 United States of America 03 Feb 2015
Methods for determining personalized treatment compositions for prostate cancer and… Grant US-8784795-B2 United States of America 22 Jul 2014
METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER Application US-20140186295-A1 United States of America 03 Jul 2014
Compositions and Methods for Diagnosing and Treating Cancer Application US-20140186342-A1 United States of America 03 Jul 2014
METHODS OF TREATING CANCER AND TESTING MUTATION ZYGOSITY RELATED THERETO Application US-20140147411-A1 United States of America 29 May 2014
METHODS OF METABOLIC TARGETING CANCER CELLS USING CHEMO- AND IMMUNOTHERAPY FOR TREATING… Application US-20140056844-A1 United States of America 27 Feb 2014
THERAPEUTIC AGENT FOR CANCER HAVING REDUCED SENSITIVITY TO MOLECULAR TARGET DRUG AND… Application US-20140056910-A1 United States of America 27 Feb 2014
ANTIBODIES SELECTIVE FOR CELLS PRESENTING EGFR AT HIGH DENSITY Application US-20130295086-A1 United States of America 07 Nov 2013
PREDICTIVE BIOMARKER FOR CANCER TREATMENT WITH ADCC-ENHANCED ANTIBODIES Application US-20130273032-A1 United States of America 17 Oct 2013
USES OF APOPTOTIC CELL-TARGETING PEPTIDES, LABEL SUBSTANCES AND LIPOSOMES CONTAINING A… Application US-20120258038-A1 United States of America 11 Oct 2012
ANTIBODY CAPABLE OF RECOGNIZING HLA CLASS I Application US-20120244142-A1 United States of America 27 Sep 2012
PD-1 ANTAGONISTS AND METHODS OF USE THEREOF Application US-20110195068-A1 United States of America 11 Aug 2011
Oncotherapeutic Application of Inhibitors of High-Affinity Glucose Transporters Application US-20110104249-A1 United States of America 05 May 2011